
Xylem Boosts Revenue 7.8% Amid Margin Gains and Strategic Deals
Xylem Inc.Description
What this story covers
Xylem Inc. reported Q3 revenue of $2.3B, up 7.8% with 6.9% organic growth, driven by North American demand and pricing. Margins expanded to 38.9% gross and 23.2% adjusted EBITDA. Acquisitions like EnviroMix enhanced digital and treatment capabilities; divestitures streamlined focus. Segments showed varied strength, backlog at $4.8B. Liquidity robust at $2.2B, outlook raised to 5-6% growth. Risks include inflation and geopolitics, managed through diversification.
Story snapshot
CompanyXylem Inc.
TickerXYL
VariantStandard detailed
Duration13:16
Filing type10-Q
PeriodQ3 2025
IndustryIndustrials & Manufacturing
Accession0001524472-25-000046
Full Story Script
Content not available for this story.